INTENSITY THERAPEUTICS, INC. Increase Decrease In Operating Lease Liability
INTENSITY THERAPEUTICS, INC. (INTS) reported Increase Decrease In Operating Lease Liability of -$142.40 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2023-11-13
- INTENSITY THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2023-09-30 was $823.00.
- INTENSITY THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2022-09-30 was -$45.89K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month |
|---|---|---|---|
| 2023-09-30 | $823.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$142.40K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$143.22K 10-Q · filed 2023-08-14 | ||
| 2022-09-30 | -$45.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$135.65K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$89.76K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |